ID   CALR_RABIT              Reviewed;         418 AA.
AC   P15253;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   03-AUG-2022, entry version 151.
DE   RecName: Full=Calreticulin;
DE   AltName: Full=CRP55;
DE   AltName: Full=Calregulin;
DE   AltName: Full=Endoplasmic reticulum resident protein 60;
DE            Short=ERp60;
DE   AltName: Full=HACBP;
DE   Flags: Precursor;
GN   Name=CALR;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae; Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Slow-twitch skeletal muscle;
RX   PubMed=2600080; DOI=10.1016/s0021-9258(20)88216-7;
RA   Fliegel L., Burns K., Maclennan D.H., Reithmeier R.A.F., Michalak M.;
RT   "Molecular cloning of the high affinity calcium-binding protein
RT   (calreticulin) of skeletal muscle sarcoplasmic reticulum.";
RL   J. Biol. Chem. 264:21522-21528(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fast-twitch skeletal muscle;
RX   PubMed=2059224; DOI=10.1016/0006-291x(91)90634-j;
RA   Fliegel L., Michalak M.;
RT   "Fast-twitch and slow-twitch skeletal muscles express the same isoform of
RT   calreticulin.";
RL   Biochem. Biophys. Res. Commun. 177:979-984(1991).
RN   [3]
RP   PROTEIN SEQUENCE OF 18-36.
RX   PubMed=2241926; DOI=10.1042/bj2710473;
RA   Treves S., de Mattei M., Lanfredi M., Villa A., Green N.M., Maclennan D.H.,
RA   Meldolesi J., Pozzan T.;
RT   "Calreticulin is a candidate for a calsequestrin-like function in Ca2(+)-
RT   storage compartments (calciosomes) of liver and brain.";
RL   Biochem. J. 271:473-480(1990).
RN   [4]
RP   PROTEIN SEQUENCE OF 18-46.
RX   PubMed=2016321; DOI=10.1016/s0021-9258(20)89624-0;
RA   Milner R.E., Baksh S., Shemanko C., Carpenter M.R., Smillie L., Vance J.E.,
RA   Opas M., Michalak M.;
RT   "Calreticulin, and not calsequestrin, is the major calcium binding protein
RT   of smooth muscle sarcoplasmic reticulum and liver endoplasmic reticulum.";
RL   J. Biol. Chem. 266:7155-7165(1991).
RN   [5]
RP   PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Lung;
RX   PubMed=1911780; DOI=10.1021/bi00105a012;
RA   Guan S., Falick A.M., Williams D.E., Cashman J.R.;
RT   "Evidence for complex formation between rabbit lung flavin-containing
RT   monooxygenase and calreticulin.";
RL   Biochemistry 30:9892-9900(1991).
RN   [6]
RP   FUNCTION.
RX   PubMed=10581245; DOI=10.1093/emboj/18.23.6718;
RA   Saito Y., Ihara Y., Leach M.R., Cohen-Doyle M.F., Williams D.B.;
RT   "Calreticulin functions in vitro as a molecular chaperone for both
RT   glycosylated and non-glycosylated proteins.";
RL   EMBO J. 18:6718-6729(1999).
RN   [7]
RP   ZINC-BINDING DOMAIN.
RX   PubMed=8521965; DOI=10.1016/0014-5793(95)01246-4;
RA   Baksh S., Spamer C., Heilmann C., Michalak M.;
RT   "Identification of the Zn2+ binding region in calreticulin.";
RL   FEBS Lett. 376:53-57(1995).
RN   [8]
RP   MUTAGENESIS OF HIS-170.
RX   PubMed=14522955; DOI=10.1074/jbc.m309497200;
RA   Guo L., Groenendyk J., Papp S., Dabrowska M., Knoblach B., Kay C.,
RA   Parker J.M., Opas M., Michalak M.;
RT   "Identification of an N-domain histidine essential for chaperone function
RT   in calreticulin.";
RL   J. Biol. Chem. 278:50645-50653(2003).
CC   -!- FUNCTION: Calcium-binding chaperone that promotes folding, oligomeric
CC       assembly and quality control in the endoplasmic reticulum (ER) via the
CC       calreticulin/calnexin cycle (PubMed:10581245). This lectin interacts
CC       transiently with almost all of the monoglucosylated glycoproteins that
CC       are synthesized in the ER. Interacts with the DNA-binding domain of
CC       NR3C1 and mediates its nuclear export (By similarity). Involved in
CC       maternal gene expression regulation. May participate in oocyte
CC       maturation via the regulation of calcium homeostasis (By similarity).
CC       Present in the cortical granules of non-activated oocytes, is
CC       exocytosed during the cortical reaction in response to oocyte
CC       activation and might participate in the block to polyspermy (By
CC       similarity). {ECO:0000250|UniProtKB:P27797,
CC       ECO:0000250|UniProtKB:P28491, ECO:0000250|UniProtKB:Q8K3H7,
CC       ECO:0000269|PubMed:10581245}.
CC   -!- SUBUNIT: Monomer. Component of an EIF2 complex at least composed of
CC       CELF1/CUGBP1, CALR, CALR3, EIF2S1, EIF2S2, HSP90B1 and HSPA5. Interacts
CC       with PDIA3/ERp57 and SPACA9 (By similarity). Interacts with TRIM21.
CC       Interacts with NR3C1. Interacts with PPIB. Interacts (via P-domain)
CC       with PDIA5. Interacts with CLCC1 (By similarity).
CC       {ECO:0000250|UniProtKB:P14211, ECO:0000250|UniProtKB:P18418,
CC       ECO:0000250|UniProtKB:P27797}.
CC   -!- INTERACTION:
CC       P15253; P05067: APP; Xeno; NbExp=3; IntAct=EBI-9005200, EBI-77613;
CC       P15253; PRO_0000000092 [P05067]: APP; Xeno; NbExp=2; IntAct=EBI-9005200, EBI-821758;
CC       P15253; PRO_0000000093 [P05067]: APP; Xeno; NbExp=2; IntAct=EBI-9005200, EBI-2431589;
CC       P15253; P12023: App; Xeno; NbExp=2; IntAct=EBI-9005200, EBI-78814;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000250|UniProtKB:P27797}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:P27797}. Secreted, extracellular space,
CC       extracellular matrix {ECO:0000250|UniProtKB:P27797}. Cell surface
CC       {ECO:0000250|UniProtKB:P27797}. Sarcoplasmic reticulum lumen
CC       {ECO:0000250|UniProtKB:P28491}. Cytoplasmic vesicle, secretory vesicle,
CC       Cortical granule {ECO:0000250|UniProtKB:Q8K3H7}. Cytolytic granule
CC       {ECO:0000250|UniProtKB:P27797}. Note=Also found in cell surface (T
CC       cells), cytosol and extracellular matrix. During oocyte maturation and
CC       after parthenogenetic activation accumulates in cortical granules. In
CC       pronuclear and early cleaved embryos localizes weakly to cytoplasm
CC       around nucleus and more strongly in the region near the cortex (By
CC       similarity). In cortical granules of non-activated oocytes, is
CC       exocytosed during the cortical reaction in response to oocyte
CC       activation (By similarity). {ECO:0000250|UniProtKB:P27797,
CC       ECO:0000250|UniProtKB:P28491, ECO:0000250|UniProtKB:Q8K3H7}.
CC   -!- DOMAIN: Can be divided into a N-terminal globular domain, a proline-
CC       rich P-domain forming an elongated arm-like structure and a C-terminal
CC       acidic domain. The P-domain binds one molecule of calcium with high
CC       affinity, whereas the acidic C-domain binds multiple calcium ions with
CC       low affinity (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The interaction with glycans occurs through a binding site in
CC       the globular lectin domain. {ECO:0000250}.
CC   -!- DOMAIN: The zinc binding sites are localized to the N-domain.
CC   -!- DOMAIN: Associates with PDIA3 through the tip of the extended arm
CC       formed by the P-domain. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the calreticulin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J05138; AAA31188.1; -; mRNA.
DR   PIR; A34154; A34154.
DR   PIR; C33208; C33208.
DR   PIR; D33208; D33208.
DR   PIR; S13046; S13046.
DR   RefSeq; NP_001075704.1; NM_001082235.1.
DR   AlphaFoldDB; P15253; -.
DR   BMRB; P15253; -.
DR   SMR; P15253; -.
DR   BioGRID; 1172073; 1.
DR   CORUM; P15253; -.
DR   IntAct; P15253; 4.
DR   PRIDE; P15253; -.
DR   GeneID; 100009050; -.
DR   KEGG; ocu:100009050; -.
DR   CTD; 811; -.
DR   InParanoid; P15253; -.
DR   Proteomes; UP000001811; Unplaced.
DR   GO; GO:0009986; C:cell surface; IEA:UniProtKB-SubCell.
DR   GO; GO:0060473; C:cortical granule; ISS:UniProtKB.
DR   GO; GO:0044194; C:cytolytic granule; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IDA:CAFA.
DR   GO; GO:0033018; C:sarcoplasmic reticulum lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IDA:CAFA.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   Gene3D; 2.10.250.10; -; 1.
DR   InterPro; IPR001580; Calret/calnex.
DR   InterPro; IPR018124; Calret/calnex_CS.
DR   InterPro; IPR009169; Calreticulin.
DR   InterPro; IPR009033; Calreticulin/calnexin_P_dom_sf.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   PANTHER; PTHR11073; PTHR11073; 1.
DR   Pfam; PF00262; Calreticulin; 2.
DR   PIRSF; PIRSF002356; Calreticulin; 1.
DR   PRINTS; PR00626; CALRETICULIN.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF63887; SSF63887; 1.
DR   PROSITE; PS00803; CALRETICULIN_1; 1.
DR   PROSITE; PS00804; CALRETICULIN_2; 1.
DR   PROSITE; PS00805; CALRETICULIN_REPEAT; 3.
DR   PROSITE; PS00014; ER_TARGET; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Calcium; Chaperone; Cytoplasm; Cytoplasmic vesicle;
KW   Direct protein sequencing; Disulfide bond; Endoplasmic reticulum;
KW   Extracellular matrix; Hydroxylation; Lectin; Lysosome; Metal-binding;
KW   Reference proteome; Repeat; Sarcoplasmic reticulum; Secreted; Signal; Zinc.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000269|PubMed:2016321,
FT                   ECO:0000269|PubMed:2241926"
FT   CHAIN           18..418
FT                   /note="Calreticulin"
FT                   /id="PRO_0000004176"
FT   REPEAT          191..202
FT                   /note="1-1"
FT   REPEAT          210..221
FT                   /note="1-2"
FT   REPEAT          227..238
FT                   /note="1-3"
FT   REPEAT          244..255
FT                   /note="1-4"
FT   REPEAT          259..269
FT                   /note="2-1"
FT   REPEAT          273..283
FT                   /note="2-2"
FT   REPEAT          287..297
FT                   /note="2-3"
FT   REGION          18..197
FT                   /note="N-domain"
FT   REGION          191..255
FT                   /note="4 X approximate repeats"
FT   REGION          193..278
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          198..308
FT                   /note="P-domain"
FT   REGION          237..270
FT                   /note="Interaction with PPIB"
FT                   /evidence="ECO:0000250"
FT   REGION          259..297
FT                   /note="3 X approximate repeats"
FT   REGION          309..418
FT                   /note="C-domain"
FT   REGION          349..418
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           415..418
FT                   /note="Prevents secretion from ER"
FT   COMPBIAS        199..254
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        352..375
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        376..418
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         26
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         62
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         64
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         109
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         111
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         128
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         135
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         317
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         328
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         48
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P27797"
FT   MOD_RES         64
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P27797"
FT   MOD_RES         159
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P27797"
FT   MOD_RES         209
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P27797"
FT   DISULFID        105..137
FT                   /evidence="ECO:0000250"
FT   VARIANT         35
FT                   /note="E -> D"
FT   MUTAGEN         170
FT                   /note="H->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:14522955"
FT   CONFLICT        90
FT                   /note="P -> T (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   418 AA;  48275 MW;  B6082B689DC763A6 CRC64;
     MLLPVPLLLG LLGLAAAEPV VYFKEQFLDG DGWTERWIES KHKSDFGKFV LSSGKFYGDQ
     EKDKGLQTSQ DARFYALSAR FEPFSNKGQP LVVQFTVKHE QNIDCGGGYV KLFPAGLDQK
     DMHGDSEYNI MFGPDICGPG TKKVHVIFNY KGKNVLINKD IRCKDDEFTH LYTLIVRPDN
     TYEVKIDNSQ VESGSLEDDW DFLPPKKIKD PDASKPEDWD ERAKIDDPTD SKPEDWDKPE
     HIPDPDAKKP EDWDEEMDGE WEPPVIQNPE YKGEWKPRQI DNPDYKGTWI HPEIDNPEYS
     PDANIYAYDS FAVLGLDLWQ VKSGTIFDNF LITNDEAYAE EFGNETWGVT KTAEKQMKDK
     QDEEQRLKEE EEEKKRKEEE EAEEDEEDKD DKEDEDEDEE DKDEEEEEAA AGQAKDEL
//
